Cited by 75Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment ApproachesInfective Endocarditis Diagnosis and Management

Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes and Severe Aortic Stenosis at High Risk for Surgery

Open access
Lindman, Brian R., Pibarot, Philippe, Arnold, Suzanne V., Suri, Rakesh M., McAndrew, Thomas C., Maniar, Hersh S., Zajarias, Alan, Kodali, Susheel +7 more·2014·Journal of the American College of Cardiology

Abstract

Objectives The goal of this study was to determine whether a less-invasive approach to aortic valve replacement (AVR) improves clinical outcomes in diabetic patients with aortic stenosis (AS).Background Diabetes is associated with increased morbidity and mortality after surgical AVR for AS.Methods Among treated patients with severe symptomatic AS at high risk for surgery in the PARTNER (Placement of Aortic Transcatheter Valve) trial, we examined outcomes stratified according to diabetes status of patients randomly assigned to receive transcatheter or surgical AVR. The primary outcome was all-cause mortality at 1 year.Results Among 657 patients enrolled in PARTNER who underwent treatment, there were 275 patients with diabetes (145 transcatheter, 130 surgical). There was a significant interaction between diabetes and treatment group for 1-year all-cause mortality (p = 0.048). Among diabetic patients, all-cause mortality at 1 year was 18.0% in the transcatheter group and 27.4% in the surgical group (hazard ratio: 0.60 [95% confidence interval: 0.36 to 0.99]; p = 0.04). Results were consistent among patients treated via transfemoral or transapical routes. In contrast, among nondiabetic patients, there was no significant difference in all-cause mortality at 1 year (p = 0.48). Among diabetic patients, the 1-year rates of stroke were similar between treatment groups (3.5% transcatheter vs. 3.5% surgery; p = 0.88), but the rate of renal failure requiring dialysis >30 days was lower in the transcatheter group (0% vs. 6.1%; p = 0.003).Conclusions Among patients with diabetes and severe symptomatic AS at high risk for surgery, this post-hoc stratified analysis of the PARTNER trial suggests there is a survival benefit, no increase in stroke, and less renal failure from treatment with transcatheter AVR compared with surgical AVR. (The PARTNER Trial: Placement of AoRTic TraNscathetER Valve Trial; NCT00530894).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2013.10.057

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Results from some recent studies suggest that TAVR might be preferable to surgical aortic valve replacement in patients with diabetes, chronic obstructive pulmonary disease, pulmonary hypertension, small aortic annulus and low-flow, low-gradient aortic stenosis.

    “Results from some recent studies suggest that TAVR might be preferable to surgical AVR in patients with diabetes, chronic obstructive pulmonary disease, pulmonary hypertension, small aortic annulus and low-flow, low-gradient AS262–266.”

    From Calcific aortic stenosis (2016) · cites this paper as [262]

    The Conclusion supports the diabetes portion of the claim: TAVR may be preferred over surgery for patients with aortic stenosis and diabetes. That finding comes from high-surgical-risk patients, a restriction the citing sentence omits. The other listed conditions are not attributed to this source alone within the citation range. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lindman, B. R., Pibarot, P., Arnold, S. V., Suri, R. M., McAndrew, T. C., Maniar, H. S., Zajarias, A., Kodali, S., Kirtane, A. J., Thourani, V. H., Tuzcu, E. M., Svensson, L. G., Waksman, R., Smith, C. R., & Leon, M. B.
Affiliations
  • Washington University in St. Louis (US)
  • Saint Luke's Hospital (US)
  • Mayo Clinic (US)
  • Cardiovascular Research Foundation (US)
  • NewYork–Presbyterian Hospital (US)
  • Emory University (US)
  • Cleveland Clinic (US)
  • MedStar Washington Hospital Center (US)
Corresponding author
Lindman, Brian R.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2014-03
Volume
63
Issue
11
Pages
1090-1099
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2166688699
Cited by
75
References
28
Citations by year
2025: 5 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 2 · 2019: 10 · 2018: 7 · 2017: 9 · 2016: 9 · 2015: 11 · 2014: 5 · 2013: 1
FWCI
5.89
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Corpus Université Laval (Université Laval) (submittedVersion)
Funders
  • Edwards Lifesciences (K23 HL116660)
  • Institute of Clinical and Translational Sciences (KL2 TR000450, UL1 TR000448)
  • National Institutes of Health
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Aortic Disease and Treatment Approaches
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
Keywords
transcatheter aortic valve implantation, surgical aortic valve replacement, diabetes mellitus, severe aortic stenosis, high surgical risk, all-cause mortality, stroke, renal failure, PARTNER trial
MeSH terms
Age Factors, Aged, Aged, 80 and over, Aortic Valve Stenosis, Diabetes Mellitus, Type 2, Evaluation Studies as Topic, Female, Follow-Up Studies, Cardiac Catheterization, Heart Valve Prosthesis, Humans, Male, Postoperative Complications, Severity of Illness Index, Sex Factors, Echocardiography, Doppler, Survival Rate, Proportional Hazards Models, Treatment Outcome, Hospital Mortality, Risk Assessment, Statistics, Nonparametric, Minimally Invasive Surgical Procedures, Heart Valve Prosthesis Implantation, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review